Multimodality therapy in advanced paranasal sinus carcinoma: Superior long-term results

Cancer Journal from Scientific American

Volumn 5, Issue 4, 1999, Pages 219-223

  Lee, Misa M ^a   Vokes, Everett E ^a   Rosen, Arie ^b   Witt, Mary Ellyn ^a   Weichselbaum, Ralph R ^a   Haraf, Daniel J ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Long term complication; Multimodality therapy; Paranasal sinus cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HEAD AND NECK SURGERY; HUMAN; MALE; PARANASAL SINUS CARCINOMA; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PARANASAL SINUS NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032748351     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Roush GC. Epidemiology of cancer of the nose and paranasal sinuses: current concepts. Head Neck Surg 1979;2:3-11.
2. Tsujii H, Kamada T, Arimoto T et al. The role of radiotherapy in the management of maxillary sinus carcinoma. Cancer 1986;57:2261-2266.
3. St-Pierre S, Baker SR. Squamous cell carcinoma of the maxillary sinus: Analysis of 66 cases. Head Neck Surg 1983;5:508-513.
4. Bush SE, Bagshaw MA. Carcinoma of the paranasal sinuses. Cancer 1982;50:154-158.
5. Spiro JD, Soo KC, Spiro RH. Squamous carcinoma of the nasal cavity and paranasal sinuses. Am J Surg 1989;158:328-332.
6. Shibuya H, Horiuchi J, Suzuki S et al. Maxillary sinus carcinoma: result of radiation therapy. Int J Radiat Oncol Biol Phys 1984;10:1021-1026.
7. Parson JT, Mendenhall WM, Mancuso AA et al. Malignant tumors of the nasal cavity and ethmoid and sphenoid sinuses. Int J Radiat Oncol Biol Phys 1988;14:11-22.
8. Beale F, Garrett P. Cancer of the paranasal sinuses with particular reference to maxillary sinus cancer. J Otolaryngol 1983;12:377-382.
9. Lee F, Ogura J. Maxillary sinus carcinoma. Laryngoscope 1981;91:133-139.
10. Jiang G, Ang K, Peters L et al. Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy. Radiat Oncol 1991;21:193-200.
11. Issacs J, Mooney S, Mendenhall W et al. Cancer of the maxillary sinus treated with surgery and/or radiation therapy. Am J Surg 1990;56:327-330.
12. Rosen A, Vokes E, Scher N et al. Locoregionally advanced paranasal sinus carcinoma: favorable survival with multimodality therapy. Arch Otolaryngol Head Neck Surg 1993; 119:743-746.
13. Vokes EE, Moran WJ, Mick R et al. Neoadjuvant and adjuvant methotrexate cisplatin and fluorouracil in multimodality therapy of head and neck cancer. J Clin Oncol 1989; 7:838-845.
14. Vokes EE, Panje WR, Meek R et al. A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy for locally advanced head and neck cancer. Cancer 1990;66:206-213.
15. Vokes EE, Schilsky RL, Weichselbaum RR et al. Induction chemotherapy with cisplatin, fluorouracil, and high dose leucovorin for advanced head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol 1990;8:241-247.
16. Vokes EE, Haraf DJ, McEvilly RM et al. Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemotherapy for advanced head and neck cancer: a feasible and active approach. Ann Oncol 1992;3:79-81.
17. Kies MS, Haraf DJ, Athanasiadis I et al. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol 1998;16:2715-2721.
18. Kaplan E, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-463.
19. Boone ML, Harle TS, Higholt HW et al. Malignant disease of the paranasal sinuses and nasal cavity: importance of precise localization of extent of disease. Am J Roentgenol Radiat Ther Nucl Med 1968;102:627-636.
20. Osguthorpe JD, Patel S. Craniofacial approaches to sinus malignancy: paranasal sinus tumors. Otolaryngol Clin North Am 1995;28:1239-1256.
21. Cheesman A, Lund V, Howard D. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses. Head Neck Surg 1986;8:429-435.
22. Amendola BE, Eiser D, Hazra TA et al. Carcinoma of the maxillary antrum: surgery or radiation therapy? Int J Radiat Oncol Biol Phys 1981;7:743-746.
23. Lund V, Howard D, Wei W et al. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: a 17 year experience. Head Neck 1998;20:97-105.
24. Ahmad K, Cordoba RB, Fayos JV. Squamous cell carcinoma of the maxillary sinus. Arch Otolaryngol 1981;107:48-51.
25. Pearlman AW, Abadir R. Carcinoma of the maxillary antrum: the role of preoperative irradiation. Laryngoscope 1973;84:400-409.
26. Marchetta FC, Sako K, Mattick WL et al. Squamous cell carcinoma of the maxillary sinus. Am J Surg 1969;118:805.
27. Sisson GA, Toriumi DM, Atiyah RA. Paranasal sinus malignancy: a comprehensive update. Laryngoscope 1989;99:143-150.
28. Lavertu P, Roberts JK, Kraus DH et al. Squamous cell carcinoma of the paranasal sinuses: the Cleveland Clinic experience 1977-1986. Laryngoscope 1989;99:1130-1136.
29. Lee YY, Dimery IW, Van Tassel P et al. Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors. Arch Otolaryngol 1989;115:503-508.
30. Bjork-Eriksson T, Mercke C, Petruson B et al. Potential impact on tumor control and organ preservation with cisplatin and 5-fluorouracil for patients with advanced tumors of the paranasal sinuses and nasal fossa: a prospective pilot study. Cancer 1992;70:2615-2620.
31. Choi KN, Rotman M, Hassan A et al. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors. Int J Radiat Oncol Biol Phys 1997;39:823-829.
32. Brizel DM, Albers ME, Fisher SR et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338:1798-1804.